This cir cu lar was pre pared jointly by AABB, Amer ica’s Blood Cen ters, and the Amer i can Red Cross, and is rec og nized as ac cept able by the Food and Drug Ad min is tra tion. The on line ver sion of the Cir cu lar of In for ma tion may not be mod i fied in any way with out the ex press per mis sion of the AABB, ABC, and ARC. July 2002. For a printed copy of the Cir cu lar, please con tact...

Vehicular Ad hoc Networks (VANETs) allow vehicles to form a self-organized network without any fixed infrastructure. VANETs have received wide attention and numerous research issues have been identified in the recent time. The design and implementation of efficient and scalable routing protocols for VANETs is a challenging task due to high dynamics and mobility constraints. In this paper, we ha...

Insulinomas with multiple neuroendocrine tumour type 1 (MEN1) sometimes have metachronous or recurrent tumours. However, the treatment for these tumours is controversial, and published reports regarding multimodal therapy for insulinomas are limited. We report a 73-year-old woman with recurrent insulinoma with MEN1 successfully controlled by multimodal therapy. She had several complications, an...

Most receptor-like protein tyrosine phosphatases (RPTPs) contain two conserved phosphatase domains (D1 and D2) in their intracellular region. The carboxy-terminal D2 domain has little or no catalytic activity. The crystal structure of the tandem D1 and D2 domains of the human RPTP LAR revealed that the tertiary structures of the LAR D1 and D2 domains are very similar to each other, with the exc...